louisiana semaglutide vomiting lawyer glp-1 in glp-1 nausea law firm in louisiana Louisiana Diabetes Drugs & Gastrointestinal Injuries louisiana glp-1 gi obstruction attorney

Wegovy at 2.4 mg is the licensed option for weight management, producing approximately 15% body weight loss and a 20% reduction in cardiovascular events in clinical trials

Ozempic and Rybelsus are used off-label for weight management

8 Therefore, uncertainty persists

For weight management : For injection dosage form (Wegovy solution): Adults Initially, 0.25 milligrams injected underneath the skin in the thigh, abdomen, or upper arm as directed by your physician, once a week for 4 weeks

This includes current medications, disease activity level, history of nephritis or other organ involvement, and any history of medication sensitivities